Babanto, Alexa Mae B.

HRN: 23-96-03  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/04/2024
AMPICILLIN 1GM (VIAL)
05/04/2024
05/11/2024
INTRAVENOUS
250 Mg IVTT
Every 6 Hours
Empiric
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: